Biomira to present at Bear Stearns 18th Annual Healthcare Conference

EDMONTON, Sept. 8 /CNW/ - Biomira Inc. (Nasdaq: BIOM) (TSX: BRA)
announced today that Alex McPherson, MD, PhD, President and CEO of Biomira,
will present highlights of the Company's lead product and corporate plans at
the Bear Stearns 18th Annual Healthcare Conference at the Grand Hyatt Hotel,
New York, NY. The presentation will be held on Tuesday, September 13, 2005
from 8:00 a.m. until 8:25 a.m. EST.
This presentation will be Web cast. Investors may listen to the Biomira
presentation at the Bear Stearns Conference live via a link at
http://customer.talkpoint.com/BEAR002/091205a_cy/default.asp?entity     
(equal sign)biomira.

The Company

Biomira is a biotechnology company specializing in the development of
innovative therapeutic approaches to cancer management. Biomira's commitment
to the treatment of cancer currently focuses on the development of synthetic
vaccines and novel strategies for cancer immunotherapy. We are The Cancer
Vaccine People(TM).